Document is current
Any future updates will be listed below
-
Authors
White, Phillip J. https://orcid.org/0000-0002-0957-425X
Wewer Albrechtsen, Nicolai J.
Campbell, Jonathan E. https://orcid.org/0000-0003-4358-6331
- License Information
-
More Information
Article History
Accepted: 20 February 2025
First Online: 7 March 2025
Competing interests
: The group of J.E.C. receives funding for basic science from Novo Nordisk, Eli Lilly, Merck, Structure Therapeutics and Prostasis. J.E.C. has served as a consultant or speaker within the past 12 months for Arrowhead Therapeutics, Boehringer Ingelheim, Neurocrine Biosciences, Protagonist Therapeutics, Prostasis, Roche and Structure Therapeutics. The other authors declare no competing interests.
